Literature DB >> 2167778

Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.

M E Ibarra-Rubio1, C Cruz, E Tapia, J C Peña, J Pedraza-Chaverrí.   

Abstract

1. Serum angiotensin converting enzyme activity (ACEA) and plasma renin activity (PRA) were determined in rats under different experimental conditions such as: nephrotic syndrome (NS), bilateral nephrectomy (BN), renovascular hypertension (RH), dehydration (DEH), anaesthesia (AN), low sodium diet (LSD) and high sodium diet (HSD), and injection with propranolol (PRO) and isoprenaline (ISO). 2. PRA increased in LSD, AN, NS, RH, DEH and IPT groups, and decreased in HSD, BN, and PRO groups. Serum ACEA did not change in RH, HSD, IPT, DEH, AN, and PRO groups, increased in NS group, and decreased in LSD and BN groups. 3. Serum ACEA changed in the opposite direction to PRA only in the LSD group. This finding suggests that ACE may limit the full expression of the renin-angiotensin system in the LSD group, but not in the other groups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167778     DOI: 10.1111/j.1440-1681.1990.tb01338.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Renal and myocardial histopathologic changes in two kidney--one clip renovascular hypertenson.

Authors:  A Gözey; S Paydaş; A Dogan; G Gönlüşen; B Ozaykan; I Tuncer; M Kibar
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Angiotensin converting enzyme activity and nitric oxide level in serum patients with dehydration.

Authors:  Jasminko Huskić; Filip Culo; Sajma Dautović; Nedzad Mulabegović
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

3.  Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.

Authors:  Diego Lezama-Martínez; Ignacio Valencia-Hernández; Jazmin Flores-Monroy; Luisa Martínez-Aguilar
Journal:  Dose Response       Date:  2017-11-12       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.